These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 6351043

  • 21. Beneficial effects of nifedipine on regional myocardial blood flow in patients with coronary artery disease.
    Malacoff RF, Lorell BH, Mudge GH, Holman BL, Idoine J, Bifolck L, Cohn PF.
    Circulation; 1982 Jan; 65(1 Pt 2):I32-7. PubMed ID: 7053296
    [Abstract] [Full Text] [Related]

  • 22. [Effect of digoxin on coronary circulation and myocardial O2-consumption in patients with angina pectoris].
    Kötter V, Schüren KP, Schröder R.
    Verh Dtsch Ges Inn Med; 1982 Jan; 83():1644-7. PubMed ID: 611900
    [No Abstract] [Full Text] [Related]

  • 23. New angina drugs.
    FDA Drug Bull; 1982 Apr; 12(1):1-3. PubMed ID: 7075924
    [No Abstract] [Full Text] [Related]

  • 24. Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease.
    Kern MJ, Petru MA, Ferry DR, Eilen SD, Barr WK, Porter CB, O'Rourke RA.
    J Am Coll Cardiol; 1985 Jun; 5(6):1438-50. PubMed ID: 2860147
    [Abstract] [Full Text] [Related]

  • 25. What is preferable in unstable angina, beta-blockade or calcium-inhibition?
    Hugenholtz PG, Serruys PW, Simoons ML.
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():199-209. PubMed ID: 6134510
    [Abstract] [Full Text] [Related]

  • 26. [Analogy of response to acute and chronic nifedipine therapy in hypertensive and non-hypertensive patients].
    Longhini C, Pinelli G, Portaluppi F, Toselli T, Ravenna F, Manini GL, Dominici P, Pedrielli F.
    Boll Soc Ital Cardiol; 1979 Feb; 24(7):779-82. PubMed ID: 554666
    [No Abstract] [Full Text] [Related]

  • 27. [Calcium antagonists in acute coronary insufficiency].
    Piccolo E, Cazzin R, Trevi GP, Pascotto P, Totaro G, Raviele A.
    Boll Soc Ital Cardiol; 1978 Feb; (1 Suppl):135-41. PubMed ID: 757675
    [No Abstract] [Full Text] [Related]

  • 28. Influence of nifedipine left ventricular systolic and diastolic function. Relationships to manifestations of ischemia and congestive failure.
    Ludbrook PA, Tiefenbrunn AJ, Sobel BE.
    Am J Med; 1981 Oct; 71(4):683-92. PubMed ID: 7282756
    [No Abstract] [Full Text] [Related]

  • 29. [Protective effect of nicardipine hydrochloride on the perfused ischemic canine myocardium].
    Sunamori M, Okamura T, Amano J, Suzuki A.
    Kokyu To Junkan; 1983 Nov; 31(11):1241-4. PubMed ID: 6676796
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia.
    Jolly SR, Hardman HF, Gross GJ.
    J Pharmacol Exp Ther; 1981 Apr; 217(1):20-5. PubMed ID: 7205654
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of nifedipine therapy for refractory angina pectoris.
    Stone PH, Turi ZG, Muller JE.
    Am Heart J; 1982 Sep; 104(3):672-81. PubMed ID: 6126113
    [No Abstract] [Full Text] [Related]

  • 32. Calcium antagonists.
    Conti CR, Pepine CJ, Feldman RL, Hill JA.
    Cardiology; 1985 Sep; 72(5-6):297-321. PubMed ID: 2866840
    [Abstract] [Full Text] [Related]

  • 33. [New aspects of the treatment of angina pectoris and hypertension. 2d Mediterranean symposium, Madrid, 19 and 20 September 1980].
    Rev Esp Cardiol; 1982 Sep; 35(5 Suppl 2):II1-122. PubMed ID: 7170399
    [No Abstract] [Full Text] [Related]

  • 34. [Pharmacology of calcium antagonists].
    Klaus W.
    Fortschr Med; 1984 Jul 26; 102(27-28):728-31. PubMed ID: 6479816
    [Abstract] [Full Text] [Related]

  • 35. The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension.
    Sierra C, Coca A.
    Expert Rev Cardiovasc Ther; 2008 Sep 26; 6(8):1055-62. PubMed ID: 18793108
    [Abstract] [Full Text] [Related]

  • 36. Mechanism of action of calcium-channel-blocking agents.
    Braunwald E.
    N Engl J Med; 1982 Dec 23; 307(26):1618-27. PubMed ID: 6292718
    [No Abstract] [Full Text] [Related]

  • 37. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.
    Sorkin EM, Clissold SP, Brogden RN.
    Drugs; 1985 Sep 23; 30(3):182-274. PubMed ID: 2412780
    [No Abstract] [Full Text] [Related]

  • 38. Selective improvement in subendocardial perfusion distal to a flow-limiting coronary artery stenosis: effects of the new calcium channel blocking agent, FR 34235, nifedipine and diltiazem.
    Gross GJ, Warltier DC.
    J Pharmacol Exp Ther; 1984 Mar 23; 228(3):531-6. PubMed ID: 6707908
    [Abstract] [Full Text] [Related]

  • 39. Effects of a new calcium antagonist, CD-832, on isoproterenol-induced myocardial ischemia in dogs with partial coronary stenosis.
    Takahashi T, Takahashi K, Kishi-Tanikawa S, Tsuchida K, Araki H, Higuchi S.
    J Pharmacol Exp Ther; 1996 Sep 23; 278(3):1028-33. PubMed ID: 8819482
    [Abstract] [Full Text] [Related]

  • 40. Clinical use of calcium channel blockers.
    Galle JS.
    Conn Med; 1983 Oct 23; 47(10):605-10. PubMed ID: 6627936
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.